GHRP-6 and CJC-1295 without DAC (Modified GRF 1-29) are synthetic research peptides that are frequently used together in experimental models to investigate the regulation of the growth hormone axis and the signaling mechanisms of the pituitary.
Browse nearby entries from the full catalog, starting with Vial Kits.
Start with adjacent compounds, or send one straight to the assistant for a comparison prompt.
Ask AssistantGHRP-6 and CJC-1295 without DAC (Modified GRF 1-29) are synthetic research peptides that are frequently used together in experimental models to investigate the regulation of the growth hormone axis and the signaling mechanisms of the pituitary. GHRP-6 is a hexapeptide growth hormone secretagogue that binds to the growth hormone secretagogue receptor (GHS-R1a) and activates Gq/PLC-dependent calcium signaling pathways involved in GH release. CJC-1295 without DAC is a stabilized analog of growth hormone-releasing hormone (GHRH 1-29) that activates the GHRH receptor and stimulates adenylate cyclase as well as cAMP-mediated signals. Preclinical studies show that combined GHS-R1a agonists and GHRH analogs are used to investigate synergistic somatotrophic signaling, hypothalamic-pituitary feedback, and peptide-mediated endocrine regulation.
Jump from this product into the newest URLs, recent updates, and grouped hubs.
Short-acting GHRH analog + GHSR agonist in one vial for studying pituitary axis coordination.
Synthetic fraction of the protein thymosin beta-4, used to investigate actin polymerization and cell migration in recovery contexts.
5-amino-1MQ is a small-molecule research compound that acts as a selective nicotinamide-N-methyltransferase (NNMT) inhibitor.
Acetyl Hexapeptide-3 (Argireline) is a hexapeptide analogue of SNAP-25 (Ac-Glu-Glu-Met-Gln-Arg-Arg-NHâ‚‚), developed to modulate vesicle docking and the release of catecholamines by inhibiting SNARE complex formation.
The definitive guide to peptide legality — covering BPC-157, TB-500, and other research peptides. What's legal, what's restricted, and what's changing in 2025-2026.
Comprehensive guide to BPC-157 dosing — injection, oral, and nasal protocols. How to reconstitute, calculate doses, and structure your cycle based on commonly reported approaches.
Supporting documents typically expected alongside the product profile.
This page is compiled from publicly available research material and normalized for browsing inside the catalog.